Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Carmot Therapeutics and Amgen extend research collaboration

Feb. 17, 2016

VBI and GSK enter vaccine research collaboration

Feb. 10, 2016

City of Hope develops technology to create cell-permeable antibodies

Feb. 10, 2016

NIH grant supports research at Scripps into nuclear receptors

Feb. 5, 2016

Exosome-encapsulated paclitaxel shows promise to treat drug-resistant cancers

Feb. 4, 2016

Human fallopian tube organoid model faithfully recapitulates the mucosal fold architecture

Feb. 4, 2016

New AAV variant transfers genes throughout the CNS in vivo

Feb. 4, 2016

Ligand licenses use of OmniAb platform to Tizona Therapeutics

Feb. 3, 2016

Mission Therapeutics raises funding to develop deubiquitinating enzyme modulators

Feb. 2, 2016

OptiNose announces pipeline project to evaluate unique nasal drug delivery technology

Feb. 2, 2016

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...